Efficacy of a 2-MNG- Containing Depigmenting Serum in the Treatment of Post-Inflammatory Hyperpigmentation Dec. 2025
Efficacy of a 2-MNG-Containing Serum and Sunscreen Regimen on Improving Facial Dyschromia in Women with Skin of Color Dec. 2025
Pigmentary Disorders around the World: Self-Reported Prevalence and Impact on QOL and Social Stigmatization Dec. 2025
Efficacy and Tolerability of a New Facial 2‑Mercaptonicotinoyl Glycine‑Containing Depigmenting Serum Versus Hydroquinone 4% over 3‑Month Treatment of Facial Melasma Dec. 2025
2-Mercaptonicotinoyl glycine, a new potent melanogenesis inhibitor, exhibits a unique mode of action while preserving melanocyte integrity May. 2025
A Bayesian network meta-analysis of 14 molecules inhibiting UV daylight-induced pigmentation Mar. 2024
Patient unique stigmatization holistic tool in dermatology (PUSH-D): development and validation of a dermatology specific stigmatization assessment tool. Feb. 2024
Topical prevention from high energy visible light-induced pigmentation by 2-mercaptonicotinoyl glycine Mar. 2026
Jul. 2023
